Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
EV to Sales HistoryFair Value
Percentile Rank43
3Y CAGR+9.7%
5Y CAGR+0.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+9.7%/yr
vs -14.0%/yr prior
5Y CAGR
+0.9%/yr
Recent acceleration
Acceleration
+23.6pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.50 | +3.8% |
| 2024 | 9.15 | -5.2% |
| 2023 | 9.66 | +34.0% |
| 2022 | 7.21 | +7.5% |
| 2021 | 6.70 | -26.2% |
| 2020 | 9.08 | -29.7% |
| 2019 | 12.92 | -1.8% |
| 2018 | 13.15 | -9.7% |
| 2017 | 14.56 | +40.8% |
| 2016 | 10.34 | - |